![Frontiers | Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis Frontiers | Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis](https://www.frontiersin.org/files/Articles/682849/fonc-11-682849-HTML/image_m/fonc-11-682849-g001.jpg)
Frontiers | Survival Outcomes in Patients With 2018 FIGO Stage IA2–IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis
![Treatment of Early Stage High-Risk Endometrioid-Type Endometrial Cancer and Patterns of Disease Relapse: A Retrospective Analysis - Advances in Radiation Oncology Treatment of Early Stage High-Risk Endometrioid-Type Endometrial Cancer and Patterns of Disease Relapse: A Retrospective Analysis - Advances in Radiation Oncology](https://www.advancesradonc.org/cms/asset/1151d1e3-41d9-4464-b2d6-8d6874a3e278/gr1.jpg)
Treatment of Early Stage High-Risk Endometrioid-Type Endometrial Cancer and Patterns of Disease Relapse: A Retrospective Analysis - Advances in Radiation Oncology
![Cancers | Free Full-Text | Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making? Cancers | Free Full-Text | Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?](https://www.mdpi.com/cancers/cancers-13-03988/article_deploy/html/images/cancers-13-03988-g001.png)
Cancers | Free Full-Text | Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
![Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer | Scientific Reports Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-03975-5/MediaObjects/41598_2021_3975_Fig1_HTML.png)
Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer | Scientific Reports
![Table 4 from The revised FIGO staging system for uterine malignancies: implications for MR imaging. | Semantic Scholar Table 4 from The revised FIGO staging system for uterine malignancies: implications for MR imaging. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d8a8f8411b116ba21122cef9f76f985ac21c278d/7-Table4-1.png)
Table 4 from The revised FIGO staging system for uterine malignancies: implications for MR imaging. | Semantic Scholar
![Cancers | Free Full-Text | FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era Cancers | Free Full-Text | FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era](https://www.mdpi.com/cancers/cancers-12-01770/article_deploy/html/images/cancers-12-01770-g005.png)
Cancers | Free Full-Text | FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era
![Cancers | Free Full-Text | Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification Cancers | Free Full-Text | Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification](https://pub.mdpi-res.com/cancers/cancers-13-05848/article_deploy/html/images/cancers-13-05848-g001.png?1637567362)
Cancers | Free Full-Text | Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
![Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems | Scientific Reports Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-86283-2/MediaObjects/41598_2021_86283_Fig1_HTML.png)
Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems | Scientific Reports
![Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018 | SpringerLink Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018 | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00330-020-07632-9/MediaObjects/330_2020_7632_Fig2_HTML.png)
Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018 | SpringerLink
![PDF] Diagnostic Value of Pelvic MRI for Assessment of the Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer: Comparison of New Versus Old FIGO Staging | Semantic Scholar PDF] Diagnostic Value of Pelvic MRI for Assessment of the Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer: Comparison of New Versus Old FIGO Staging | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/29e21e22d9ac379f83e40cd520d75d9e9b4c0a92/3-Table2-1.png)